Veradigm Inc. signed a definitive agreement to acquire Cascade Bio, Inc. on February 21, 2024. The transaction is subject to ScienceIO stockholder approval. The Merger is expected to close as promptly as practicable following the satisfaction of customary closing conditions.

Ryan Gunderson of Gunderson Dettmer Stough Villeneuve Franklin & Hachigian, LLP served as legal advisor to Cascade Bio, Inc. and John Tamisiea of McDermott Will & Emery LLP served as legal advisor to Veradigm Inc. Barclays acted as financial advisor to Cascade Bio, Inc.